1. Home
  2. RGEN vs NIO Comparison

RGEN vs NIO Comparison

Compare RGEN & NIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$176.52

Market Cap

10.0B

Sector

Health Care

ML Signal

HOLD

Logo NIO Inc. American depositary shares each  representing one ordinary share

NIO

NIO Inc. American depositary shares each representing one ordinary share

HOLD

Current Price

$3.67

Market Cap

12.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGEN
NIO
Founded
1981
2014
Country
United States
China
Employees
2000
N/A
Industry
Medical/Dental Instruments
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.0B
12.7B
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
RGEN
NIO
Price
$176.52
$3.67
Analyst Decision
Buy
Buy
Analyst Count
12
10
Target Price
$167.67
$6.73
AVG Volume (30 Days)
914.0K
33.2M
Earning Date
05-05-2026
06-02-2026
Dividend Yield
N/A
N/A
EPS Growth
286.96
N/A
EPS
0.24
N/A
Revenue
$141,236,000.00
N/A
Revenue This Year
$14.30
$52.58
Revenue Next Year
$14.52
$18.91
P/E Ratio
$742.46
N/A
Revenue Growth
35.10
N/A
52 Week Low
$100.99
$3.55
52 Week High
$188.73
$8.02

Technical Indicators

Market Signals
Indicator
RGEN
NIO
Relative Strength Index (RSI) 61.30 29.74
Support Level $158.15 N/A
Resistance Level $188.73 $5.22
Average True Range (ATR) 6.73 0.12
MACD -0.25 -0.01
Stochastic Oscillator 79.98 13.37

Price Performance

Historical Comparison
RGEN
NIO

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

About NIO NIO Inc. American depositary shares each representing one ordinary share

Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations, such as battery swapping and autonomous driving. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold around 326,000 EVs in 2025, accounting for about 2% of China's passenger new energy vehicle market.

Share on Social Networks: